Sequential treatment with alectinib in crizotinib-resistant non-small-cell lung cancer

Lignende værker

• Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
  af: Talreja, Vikas T., et al.
  Udgivet: (2019)
• Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
  af: Noronha, Vanita, et al.
  Udgivet: (2017)
• Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
  af: Talreja, Vikas T., et al.
  Udgivet: (2020)
• An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome
  af: Talreja, Vikas T., et al.
  Udgivet: (2020)
• ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes
  af: Joshi, Amit, et al.
  Udgivet: (2019)